Haitong Securities(600837) 证券之星·2025-04-03 11:46Core Viewpoint - Shaanxi Sirui Advanced Materials Co., Ltd. is planning to issue A-shares to specific investors, with the total fundraising amount not exceeding 600 million yuan, aimed at supporting various projects including the industrialization of liquid rocket engine components and the construction of a technology industrial park [1][11]. Section 1: Basic Information of the Securities Issuance - The lead underwriter for the issuance is Haitong Securities Co., Ltd. [1] - The designated representatives for the project are Lin Wenting and Zhao Zhongtang, both experienced in investment banking [2][3]. - The project coordinator is Chen Qiuyue, who has participated in several IPO projects [3]. Section 2: Issuer Information - Shaanxi Sirui Advanced Materials Co., Ltd. was established on July 11, 1995, and became a joint-stock company on December 30, 2015, with a registered capital of 727,337,890 yuan [4]. - The company is listed on the Shanghai Stock Exchange under the stock code 688102 [4]. Section 3: Financial Data - As of September 30, 2024, the total assets of the company amounted to 200,822.78 million yuan, with total liabilities of 89,195.92 million yuan, resulting in total equity of 111,626.86 million yuan [5]. - For the first nine months of 2024, the company reported operating income of 96,430.81 million yuan and a net profit of 7,925.46 million yuan [5]. Section 4: Issuance Details - The type of shares to be issued is RMB ordinary shares (A-shares) with a par value of 1.00 yuan per share [7]. - The issuance will be directed towards no more than 35 specific investors, including various financial institutions and qualified individual investors [8]. - The pricing will be based on the average trading price of the company's shares over the 20 trading days prior to the issuance date, with a minimum price set at 80% of this average [8][9]. Section 5: Use of Proceeds - The proceeds from the issuance will be allocated to projects including the industrialization of liquid rocket engine components and the production of medical imaging equipment, with a total investment of 69,000 million yuan planned for these projects [11][19]. Section 6: Compliance and Approval - The issuance has undergone necessary internal reviews and has been approved by the board of directors and shareholders, complying with relevant laws and regulations [17][18]. - The company assures that the fundraising aligns with national industrial policies and will contribute to the development of the commercial aerospace sector [19][20].